Catalyst Wire Dossier Catalyst Wire Dossier

ATEV

· Humacyte, Inc.
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for ATEV, covering 2025-03-18 to 2025-03-18. Get the full timeline:

Most recent: Clinical Trial Update: To Compare the Efficacy and Safety of the ATEV With AVF in Female Patients With End-Stage Renal Disease Requiring Hemodialysis [Phase 3]

See pricing